End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
115.00 INR | +4.55% | +13.58% | +1.77% |
Sales 2023 | 1,198 M 14.37 M | Sales 2024 * | - | Capitalization | 732 M 8.78 M |
---|---|---|---|---|---|
Net income 2023 | 9.00 M 108,009 | Net income 2024 * | - | EV / Sales 2023 | 0,71x |
Net Debt 2023 | 124 M 1.49 M | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 | 80,8x | P/E ratio 2024 * | Employees | 29 | |
Yield 2023 | - | Yield 2024 * |
-
| Free-Float | 13.73% |
More Fundamentals
* Assessed data
More news
1 day | +4.55% | ||
1 week | +13.58% | ||
Current month | +19.48% | ||
1 month | +7.38% | ||
3 months | -17.27% | ||
6 months | -22.17% | ||
Current year | +1.77% |
1 week
115.00
115.00

1 month
90.25
115.00

Current year
90.25
148.75

1 year
83.00
148.75

3 years
33.10
148.75

5 years
30.50
148.75

10 years
30.50
148.75

Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 2002 | |
Director of Finance/CFO | 38 | 2017 | |
Rajni Dawani
CMP | Compliance Officer | - | 2022 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 38 | 2004 | |
Chief Executive Officer | 62 | 2002 | |
Director of Finance/CFO | 38 | 2017 |
Date | Price | Change | Volume |
---|---|---|---|
23-11-23 | 115.00 | +4.55% | 1,000 |
End-of-day quote Bombay Stock Exchange, November 22, 2023
More quotes
Chandra Bhagat Pharma Ltd is an India-based pharmaceutical company. The Company is engaged in the business of marketing pharmaceutical formulation and products in domestic and international markets through its distribution network and sales force under its own brand. It is also engaged in the business of marketing pharmaceutical critical care & health care products. It offers a wide range of product portfolio of pharmaceutical formulation including intravenous (IV) & intramuscular (IM) range injections, and a few tablets to cater the domestic & export market. It has established presence in major therapeutic categories for formulations such as anticancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, neurology etc. It is engaged in promoting and marketing of active pharmaceuticals ingredients (API's) in India.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Q4 2024 Earnings Release (Projected)
1st Jan change | Capi. (M$) | |
---|---|---|
+1.77% | 10 M $ | |
+61.90% | 532 B $ | |
+46.67% | 464 B $ | |
-14.23% | 364 B $ | |
-13.99% | 246 B $ | |
-18.80% | 216 B $ | |
+2.06% | 201 B $ | |
-11.72% | 195 B $ | |
-41.61% | 170 B $ | |
+1.03% | 141 B $ |